World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 14 November 2022
Main ID:  ACTRN12618000561280
Date of registration: 13/04/2018
Prospective Registration: Yes
Primary sponsor: Department of Obstetrics and Gynecology, Ahmadi hospital, Kuwait.
Public title: Relation between chronic endometritis and recurrent miscarriage
Scientific title: Relation between chronic endometritis and recurrent miscarriage
Date of first enrolment: 08/05/2018
Target sample size: 120
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12618000561280.aspx
Study type:  Interventional
Study design:  Purpose: Diagnosis; Allocation: Non-randomised trial;  
Phase:  Not Applicable
Countries of recruitment
Kuwait
Contacts
Name: Prof Ibrahim A. Abdelazim    
Address:  Address: Ahmadi Hospital, Kuwait Oil Company (KOC), Kuwait, P.O. Box: 9758, 61008 Ahmadi, Kuwait. Kuwait
Telephone: +965-66551300
Email: dr.ibrahimanwar@gmail.com
Affiliation: 
Name: Prof Ibrahim A. Abdelazim    
Address:  Address: Ahmadi Hospital, Kuwait Oil Company (KOC), Kuwait, P.O. Box: 9758, 61008 Ahmadi, Kuwait. Kuwait
Telephone: +965-66551300
Email: dr.ibrahimanwar@gmail.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Patients and methods: Analysis of the hospital records over the last 5 years from January 2012 to January 2017 to identify women with unexplained recurrent miscarriage, after approval of the Obstetrics and Gynecology department.
Inclusion criteria includes; women who will give consent, >20-40 years, with 3 or more miscarriages before 22 weeks’ gestation.

Exclusion criteria: Exclusion criteria includes; family history of RM, uterine abnormalities, hormonal or metabolic disorders, severe male factor infertility, previous surgery for myoma and/or endometriosis, clinical or ultrasound diagnosis of endometriosis, known clinical autoimmune disease, anti-phospholipid syndrome (APS), thrombophilic condition requiring anticoagulant therapy, and unwilling to give informed consent.

Age minimum: 20 Years
Age maximum: 40 Years
Gender: Females
Health Condition(s) or Problem(s) studied
Chronic endometritis ;
Chronic endometritis
Reproductive Health and Childbirth - Antenatal care
Reproductive Health and Childbirth - Fetal medicine and complications of pregnancy
Intervention(s)
Analysis of the hospital records over the last 5 years from January 2012 to January 2017 to identify women with unexplained recurrent miscarriage, after approval of the Obstetrics and Gynecology department of Ahmadi hospital. Inclusion criteria includes; women who will give consent, >20-40 years, with 3 or more miscarriages before 22 weeks’ gestation.
Studied women will go under diagnostic hysteroscopy in the follicular phase of the menstrual cycle, and endometrial biopsy for histological examination.
Studied women diagnosed with chronic endometritis during hysteroscopy will scheduled for endometrial biopsy in the follicular phase of the subsequent cycle, The endometrial biopsy will be cultured for the common infectious pathogens which include; Neisseria gonorrhea, Chlamydia trachomatis, Mycoplasma species, Ureaplasma urealyticum, and yeast at the endometrial levels.
Outcome measures; the relation between chronic endometritis and recurrent miscarriage.
Duration of observation for each studied woman will be 5 weeks,

Primary Outcome(s)
Outcome measures; the relation between chronic endometritis and recurrent miscarriage.
Studied women will go under diagnostic hysteroscopy in the follicular phase of the menstrual cycle, with thorough evaluation of the endometrial mucosa.
Chronic endometritis defined as demonstration of micro-polyps that fluctuate in the cavity, stromal edema, and focal or diffuse hyperemia.
The surgeon will take an endometrial biopsy from studied women with evidence of chronic endometritis during hysteroscopic examination for histological examination. Studied women diagnosed with chronic endometritis during hysteroscopy will scheduled for endometrial biopsy in the follicular phase of the subsequent cycle, for cultural, and histological examinations.
Endometrial samples were diluted in 2 ml of saline, and divided into 2 samples, one for cultures, and the other placed in formalin for histological examination.
[Outcome measures; the relation between chronic endometritis and recurrent miscarriage.
Duration of observation for each studied woman will be 5 weeks,]
Causative organism for chronic endometritis using culture for the endometrial samples taken during hysteroscopy. [Results of endometrial culture takes about 3-5 days. ]
Secondary Outcome(s)
None [None ]
Secondary ID(s)
None
Source(s) of Monetary Support
Department of Obstetrics and Gynecology, Ahmadi hospital, Kuwait.
Secondary Sponsor(s)
Ibrahim A. Abdelazim
Souad Al-Ajmi
Mohannad AbuFaza
Ethics review
Status: Approved
Approval date: 25/12/2017
Contact:
Department of Obstetrics and Gynecology, Ahmadi hospital, Kuwait.
Results
Results available: Yes
Date Posted: 22/11/2021
Date Completed: 01/10/2020
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history